NEUROTHERAPEUTICS LTD

Executive Summary

Neurotherapeutics Ltd is a technology-driven medical equipment manufacturer strategically positioned within the electrotherapeutic device niche. Its strong academic and management leadership, supported by recent capital injections, provides a solid foundation to advance product development and commercialization. However, the company must carefully manage its cash burn, navigate regulatory hurdles, and build operational capacity to capitalize on growth opportunities and mitigate competitive and market risks.

View Full Analysis Report →

Who controls this company?

Professor Georgina Margaret Jackson

HISTORIC INFORMATION
Ceased on
2021-08-05
Correspondence address
The Ingenuity Centre, University Of Nottingham Innovation Park, Triumph Road, Nottingham, England, NG7 2TU
Date of birth
October 1956
Notified on
2021-02-12
Nationality
British
Country of residence
England
Nature of control
Owns between 25% and 50% of the company's shares
Has between 25% and 50% of the voting rights in the company

Dr Barbara Morera Maiquez

HISTORIC INFORMATION
Ceased on
2021-08-05
Correspondence address
The Ingenuity Centre, University Of Nottingham Innovation Park, Triumph Road, Nottingham, England, NG7 2TU
Date of birth
September 1990
Notified on
2021-02-12
Nationality
Spanish
Country of residence
England
Nature of control
Owns between 25% and 50% of the company's shares
Has between 25% and 50% of the voting rights in the company

Professor Stephen Raymond Jackson

HISTORIC INFORMATION
Ceased on
2021-08-05
Correspondence address
The Ingenuity Centre, University Of Nottingham Innovation Park, Triumph Road, Nottingham, England, NG7 2TU
Date of birth
March 1958
Notified on
2021-02-12
Nationality
British
Country of residence
England
Nature of control
Owns between 25% and 50% of the company's shares
Has between 25% and 50% of the voting rights in the company


More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company